Source:http://linkedlifedata.com/resource/pubmed/id/19255723
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2010-3-3
|
pubmed:abstractText |
The pentacyclic 1,4-naphthoquinones 1a-d were cytotoxic (IC(50) approximately 2-7 microM) to human leukemic cell lines K562 (oxidative stress-resistant), Lucena-1 (MDR phenotype) and Daudi. Fresh leukemic cells obtained from patients, some with the MDR phenotype, were also sensitive to these compounds. The pentacyclic 1,4-naphthoquinones 1a and 1c induced apoptotic cell death in cells from leukemic patients as determined by flow cytometry. Conversely, the cell lines were highly insensitive to lapachol (2) and alpha-lapachone (3). Mitomycin-C inhibited cell proliferation at concentrations as low as 0.5 microM. The low toxicity against lymphocytes activated by phytohemagglutinin shows that these compounds are selective for the cancer cells studied. Previous data suggest that these compounds (1a-d) can be bioactivated in situ by reduction followed by rearrangement leading to enones, which are powerful alkylating agents. In contrast, lapachol (2) and beta-lapachone (3), which cannot be bioactivated by reduction, showed little activity against the same cell lines.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/1,4-naphthoquinone,
http://linkedlifedata.com/resource/pubmed/chemical/Mitomycin,
http://linkedlifedata.com/resource/pubmed/chemical/Naphthoquinones,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-lapachone,
http://linkedlifedata.com/resource/pubmed/chemical/lapachol
|
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
1573-0646
|
pubmed:author |
pubmed-author:BacelarThiago STS,
pubmed-author:BuarqueCamilla DCD,
pubmed-author:CastroCarolina PCP,
pubmed-author:CostaPaulo R RPR,
pubmed-author:FernandesRenata FRF,
pubmed-author:MaiaRaquel CRC,
pubmed-author:NettoChaquip DCD,
pubmed-author:RumjanekVivian MVM,
pubmed-author:SalustianoEduardo J SEJ,
pubmed-author:da SilvaAlcides J MAJ
|
pubmed:issnType |
Electronic
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
139-44
|
pubmed:meshHeading |
pubmed-meshheading:19255723-Cell Death,
pubmed-meshheading:19255723-Cell Line, Tumor,
pubmed-meshheading:19255723-Cell Proliferation,
pubmed-meshheading:19255723-Cell Survival,
pubmed-meshheading:19255723-Drug Screening Assays, Antitumor,
pubmed-meshheading:19255723-Humans,
pubmed-meshheading:19255723-Inhibitory Concentration 50,
pubmed-meshheading:19255723-Leukemia,
pubmed-meshheading:19255723-Leukocytes, Mononuclear,
pubmed-meshheading:19255723-Mitomycin,
pubmed-meshheading:19255723-Naphthoquinones
|
pubmed:year |
2010
|
pubmed:articleTitle |
Comparison of the cytotoxic effect of lapachol, alpha-lapachone and pentacyclic 1,4-naphthoquinones on human leukemic cells.
|
pubmed:affiliation |
Laboratório de Imunologia Tumoral, Instituto de Bioquímica Médica, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|